SG Americas Securities’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-22,569
| Closed | -$105K | – | 3112 |
|
|
2021
Q4 | $105K | Sell |
22,569
-3,517
| -13% | -$16.4K | ﹤0.01% | 2766 |
|
|
2021
Q3 | $222K | Buy |
26,086
+11,710
| +81% | +$99.7K | ﹤0.01% | 2910 |
|
|
2021
Q2 | $236K | Buy |
14,376
+4,263
| +42% | +$70K | ﹤0.01% | 2047 |
|
|
2021
Q1 | $223K | Buy |
10,113
+6,560
| +185% | +$145K | ﹤0.01% | 2376 |
|
|
2020
Q4 | $110K | Buy |
+3,553
| New | +$110K | ﹤0.01% | 2635 |
|
|
2020
Q3 | – | Sell |
-8,910
| Closed | -$137K | – | 3095 |
|
|
2020
Q2 | $137K | Buy |
+8,910
| New | +$137K | ﹤0.01% | 2729 |
|